Literature DB >> 29269654

Metastatic Lung Adenocarcinoma Mimicking Meningioma.

Toyoshi Yanagihara1, Nanae Seki1, Akio Hiwatashi2, Koichi Arimura3, Satoshi O Suzuki4, Isamu Okamoto1.   

Abstract

Entities:  

Keywords:  meningioma; metastatic brain tumor

Year:  2017        PMID: 29269654      PMCID: PMC5919874          DOI: 10.2169/internalmedicine.9472-17

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


× No keyword cloud information.
A 54-year-old woman was admitted because of a lung mass on computed tomography (CT), which was identified as lung adenocarcinoma with multiple pulmonary metastasis and carcinomatous pleurisy. She was also found to have a brain tumor 5 cm in diameter on magnetic resonance imaging (MRI) 2 months before admission. The mass was heterogeneous on T2-weighted imaging with surrounding edema (Picture A). Post-contrast T1-weighted imaging showed a heterogeneously enhanced right parietal mass (Picture B) with thickening of the adjacent dura matter (arrows) on repeat MRI during admission, suggesting meningioma or metastasis to meningioma. Because of an exacerbated headache, stereotactic craniotomy was performed. A macroscopic examination revealed a mass in the cerebral parenchyma without dural adhesion or dissemination. A histological examination revealed papillary proliferation of columnar tumor cells (Picture C) with TTF-1 (Picture D) and Napsin A positivity, indicating metastasis of lung adenocarcinoma to the cerebral parenchyma. It can be difficult to distinguish brain metastases from meningiomas using standard neuroimaging techniques (1,2).
Picture.

The authors state that they have no Conflict of Interest (COI).
  2 in total

1.  Metastatic breast carcinoma mimicking basal skull meningioma.

Authors:  Gregory W Schmidt; Neil R Miller
Journal:  Clin Ophthalmol       Date:  2007-09

2.  Extremely delayed renal cell carcinoma metastasis mimicking convexity meningioma.

Authors:  G Bademci; O Bozdogan; F Berdan; C Evliyaoglu
Journal:  Neurocirugia (Astur)       Date:  2008-12       Impact factor: 0.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.